1960•American Journal of PsychiatryRequires access

TRANYLCYPROMINE (PARNATE) A NEW MONOAMINE OXIDASE INHIBITOR

Frederick Lemere

Abstract

Preliminary clinical experience indicates that tranylcypromine (Parnate) is an improved type of monoamine oxidase inhibitor that appears to be more rapid in its action, effective in smaller doses (1 to 3 tablets a day–usually one tablet b. i. d.) and relatively free of side effects. It is indicated for treatment of any type of depression and sometimes for withdrawn schizophrenic patients.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 16 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Tranylcypromine, Monoamine oxidase inhibitor, Monoamine oxidase, Pharmacology, Depression (economics), Medicine, Monoamine oxidase B, Chemistry